Delusional disorder: Study from North India.

The aim of the present study was to study sociodemographic profile, clinical parameters including comorbidity, usefulness of antipsychotics especially atypicals, family history, and follow-up rates for delusional disorder. The records of all subjects who were seen in the Department of Psychiatry during a period of 10 years (i.e. 1994-2003) were reviewed. Eighty-eight subjects fulfilling the inclusion criteria were enrolled. The sample consisted predominantly of female subjects (55.7%), most of the total subjects were married and had favorable social functioning. The most common delusion was persecutory (54.5%), followed by delusion of reference (46.6%). The majority of the subjects had a comorbid psychiatric disorder. Education was negatively correlated with age at onset and positively correlated with the number of delusions. Age at onset was negatively correlated with total number of delusions. The sociodemographic profile of delusional disorder is consistent across various cultures, has high comorbidity and, when treated appropriately, responds to various antipsychotic agents.
AuthorsSandeep Grover, Parthasarathy Biswas, Ajit Avasthi
JournalPsychiatry and clinical neurosciences (Psychiatry Clin Neurosci) Vol. 61 Issue 5 Pg. 462-70 (Oct 2007) ISSN: 1323-1316 [Print] Australia
PMID17875023 (Publication Type: Journal Article)
Chemical References
  • Antipsychotic Agents
  • Adult
  • Aged
  • Aged, 80 and over
  • Alcoholism (epidemiology, genetics)
  • Antipsychotic Agents (adverse effects, therapeutic use)
  • Bipolar Disorder (diagnosis, drug therapy, epidemiology, genetics)
  • Comorbidity
  • Cross-Sectional Studies
  • Depressive Disorder, Major (diagnosis, drug therapy, epidemiology, genetics)
  • Female
  • Genetic Predisposition to Disease (genetics, psychology)
  • Humans
  • Incidence
  • India
  • Male
  • Middle Aged
  • Patient Compliance (psychology, statistics & numerical data)
  • Retrospective Studies
  • Schizophrenia, Paranoid (diagnosis, drug therapy, epidemiology, genetics)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: